Real-World Evidence. From Your Own Programme.
Persistence, compliance, and treatment duration data — structured for publication. Continuously generated.
Request DemoThe Medical Affairs Challenge
“Evidence generation is slow and expensive”
Traditional RWE studies take 18 months and cost millions. Your programme generates the same data every day — it just needs the right structure to become publication-ready evidence.
“I need local data for formulary submissions”
Hospital committees want Saudi-specific outcomes data. You have global trial data but nothing local. The local data exists in your programme — it just hasn't been structured for Medical Affairs use.
“I have no visibility into real-world dosing patterns”
You know the on-label schedule. But real-world compliance is invisible. How are patients actually taking their therapy? The answer exists in your programme data.
What You See With PACE
Persistence Analysis
How long patients stay on therapy. Segmented by indication, region, and demographics. Updated continuously — not once per commissioned study.
Compliance Metrics
Real-world dosing patterns measured against on-label schedules. Per drug, per indication, per site. Structured for regulatory and publication use.
Treatment Duration & Discontinuation
When patients stop. Why they stop. Structured for publication and formulary submissions.
Indication-Level Analytics
Deep-dive into each indication separately. Compare across your portfolio or benchmark against published literature.
Publication-Ready Outputs
Structured reports ready for peer review and regulatory submissions. What used to require a commissioned study, PACE generates continuously from your programme's own data.
Your programme generates real-world evidence every day.
PACE structures it — continuously, automatically, and at a fraction of the cost and time of traditional studies.